ROLE OF MACROPHAGE IN TUMOR MICROENVIRONMENT: PROSPECT IN CANCER IMMUNOTHERAPY

被引:0
作者
Gautam, P. K. [1 ]
Deepak, P. [1 ]
Kumar, S. [1 ]
Acharya, A. [1 ]
机构
[1] Banaras Hindu Univ, Fac Sci, Dept Zool, Varanasi 221005, Uttar Pradesh, India
关键词
macrophage; tumor associated macrophage; cancer immunotherapy; HEAT-SHOCK PROTEINS; NITRIC-OXIDE; BREAST-CANCER; ACTIVATION; CELLS; IMMUNOSUPPRESSION; PATHOPHYSIOLOGY; INFLAMMATION; EXPRESSION; PRODUCTS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Current evidence suggests an increasing role of macrophages in inflammation and tumor progression. Most tumors contain an abundant number of macrophages as a major component of their leukocyte infiltrate, which co-exist with tumor cells at the tumor microenvironment. Upon activation with soluble tumor antigens, macrophages release a distinct repertoire of growth factor, cytokines, chemokines and enzymes that inhibit growth of the tumor. However, the anti-tumor immune response induced by macrophages does not always ensue. Tumor cells themselves are capable of down-regulating macrophage phenotype and functions and anti-tumor immune responses in the tumor-bearing host. The present review aims to elucidate the role of macrophages in tumor growth and progression, invasion, metastasis, and angiogenesis at the site of tumor growth. Moreover, the effect of tumor microenvironment on the phenotype and function of macrophages, which are altered due to the continuous exposure of various soluble and non-soluble tumor promoting factors secreted by tumor cells, and implication of macrophages in cancer immunotherapy have been discussed in detail.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 43 条
  • [1] Inflammation and cancer: How hot is the link?
    Aggarwal, Bharat B.
    Shishodia, Shishir
    Sandur, Santosh K.
    Pandey, Manoj K.
    Sethi, Gautam
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1605 - 1621
  • [2] Al-Sarireh B, 2000, J ROY COLL SURG EDIN, V45, P1
  • [3] Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
    Allavena, P
    Signorelli, M
    Chieppa, M
    Erba, E
    Bianchi, G
    Marchesi, F
    Olimpio, CO
    Bonardi, C
    Garbi, A
    Lissoni, A
    de Brand, F
    Jimeno, J
    D'Incalci, M
    [J]. CANCER RESEARCH, 2005, 65 (07) : 2964 - 2971
  • [4] Liposomal vaccines - targeting the delivery of antigen
    Altin, Joseph G.
    Parish, Christopher R.
    [J]. METHODS, 2006, 40 (01) : 39 - 52
  • [5] Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes
    Alvaro, Tomas
    de la Cruz-Merino, Luis
    Henao-Carrasco, Fernando
    Villar Rodriguez, Jose Luis
    Vicente Baz, David
    Codes Manuel de Villena, Manuel
    Provencio, Mariano
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [6] ACTIVATION OF HUMAN MONOCYTE-DERIVED MACROPHAGES CULTURED ON TEFLON - RESPONSE TO INTERFERON-GAMMA DURING TERMINAL MATURATION INVITRO
    ANDREESEN, R
    GADD, S
    BRUGGER, W
    LOHR, GW
    ATKINS, RC
    [J]. IMMUNOBIOLOGY, 1988, 177 (02) : 186 - 198
  • [7] Basu S, 2006, INT IMMUNOL, V55, P958
  • [8] Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF interferon-gamma
    Bausero, MA
    PanoskaltsisMortari, A
    Blazar, BR
    Katsanis, E
    [J]. JOURNAL OF IMMUNOTHERAPY, 1996, 19 (02) : 113 - 124
  • [9] Mac-1 (CDllb/CD18) is an oligodeoxynucleotide-binding protein
    Benimetskaya, L
    Loike, JD
    Khaled, Z
    Loike, G
    Silverstein, SC
    Cao, L
    Khoury, JE
    Cai, TQ
    Stein, CA
    [J]. NATURE MEDICINE, 1997, 3 (04) : 414 - 420
  • [10] TAXOL, A MICROTUBULE-STABILIZING ANTINEOPLASTIC AGENT, INDUCES EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1 IN MACROPHAGES
    BOGDAN, C
    DING, A
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (01) : 119 - 121